Grade and stage misclassification in unfavorable intermediate vs high-risk NCCC prostate cancer candidates for RT plus short vs long-term androgen ADT

被引：0
|
作者：
Sorce, G. [1 ,2 ]
Flammia, R. S. [3 ]
Hoeh, B. [4 ]
Chierigo, F. [5 ]
Hohenhorst, L. [6 ]
Mazzone, E. [1 ,2 ]
Stabile, A. [1 ,2 ]
Gandaglia, G. [1 ,2 ]
Tian, Z. [7 ]
Tilki, D. [6 ]
Terrone, C. [4 ,5 ]
Gallucci, M. [3 ]
Chun, F. K. H. [4 ]
Saad, F. [7 ]
Shariat, S. F. [8 ]
Briganti, A. [1 ,2 ]
Montorsi, F. [1 ,2 ]
Karakiewicz, P., I [9 ]
机构：
[1] URI, Milan, Italy
[2] IRCCS Osped San Raffaele, Div Oncol, Unit Urol, Milan, Italy
[3] Policlin Umberto I Hosp, Div Urol, Rome, Italy
[4] Univ Hosp Frankfurt, Div Urol, Frankfurt, Germany
[5] IRCCS Osped Policlin San Martino, Div Urol, Genoa, Italy
[6] Univ Hosp Hamburg Eppendorf, Div Urol, Hamburg, Germany
[7] Univ Montreal, Div Urol, Montreal, PQ, Canada
[8] Med Univ Vienna, Div Urol, Vienna, Austria
[9] Univ Montreal, Hlth Ctr, Canc Prognost & Hlth Outcomes Unit, Dept Urol, Montreal, PQ, Canada
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0619
引用
收藏
页码：S926 / S927
页数：2
相关论文
共 50 条
  • [31] Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).
    James, Nicholas D.
    De Bono, Johann S.
    Spears, Melissa Ruth
    Clarke, Noel
    Mason, Malcolm David
    Dearnaley, David P.
    Ritchie, Alastair W. S.
    Russell, J. Martin
    Gilson, Clare
    Jones, Robert J.
    Gillessen, Silke
    Matheson, David
    Aung, San
    Birtle, Alison J.
    Chowdhury, Simon
    Gale, Joanna
    Malik, Zafar
    O'Sullivan, Joe M.
    Parmar, Mahesh K. B.
    Sydes, Matthew Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18)
  • [32] LONG-TERM OUTCOMES OF PTA HIGH GRADE INTERMEDIATE AND HIGH RISK BLADDER CANCER PATIENTS
    Scilipoti, Pietro
    Quarta, Leonardo
    Longoni, Mattia
    De Angelis, Mario
    Re, Chiara
    Basile, Giuseppe
    Avesani, Giulio
    Bertini, Alessandro
    Burgio, Giusy
    Pellegrino, Francesco
    Rosiello, Giuseppe
    Necchi, Andrea
    Raggi, Daniele
    Luciano, Roberta
    Colombo, Renzo
    Gandaglia, Giorgio
    Capitanio, Umberto
    Salonia, Andrea
    Montorsi, Francesco
    Briganti, Alberto
    Moschini, Marco
    JOURNAL OF UROLOGY, 2024, 211 (05): : E244 - E244
  • [33] Long-Term Oncological Outcomes for Histologically Confirmed High-Risk Prostate Cancer
    Takeda, Hayato
    Akatsuka, Jun
    Yuki, Endo
    Matsuzawa, Ichiro
    Suzuki, Yasutomo
    Hamasaki, Tsutomu
    Kimura, Go
    Kondo, Yukihiro
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2023, 90 (02) : 202 - 209
  • [34] Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis
    Dougherty, T.
    Hayes, S. B.
    Deng, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E526 - E527
  • [35] Brachytherapy plus external beam radiation. Long-term results in intermediate to high risk prostate cancer patients
    Ragde, H
    Elgamel, AA
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 366 - 366
  • [36] Effect of Long-term Hormonal Therapy (vs Short-term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on RTOG 9202
    Mirhadi, A. J.
    Hunt, D.
    Hanks, G. E.
    Peters, C. A.
    Zeitzer, K. L.
    D'Souza, D. P.
    Lawton, C. A.
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S26 - S26
  • [37] Propensity score matched analysis of major adverse cardiac events in patients with localized prostate cancer receiving short term vs long term ADT
    Yuan, Ye
    Hui, Gavin
    Gombar, Saurabh
    Aghdam, Nima
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] 125I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer
    Smile, Timothy D.
    Tom, Martin C.
    Halima, Ahmed
    Ciezki, Jay P.
    Reddy, Chandana A.
    Stephans, Kevin L.
    Mian, Omar Y.
    Zhang, Ryan X.
    Klein, Eric A.
    Campbell, Steven
    Ulchaker, James
    Angermeier, Kenneth K.
    Tendulkar, Rahul D.
    BRACHYTHERAPY, 2022, 21 (01) : 85 - 93
  • [39] Re: Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer
    Bakircioglu, Emre
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (04): : 202 - 202
  • [40] LH-RH analogue vs antiandrogen plus adjuvant RT in high risk prostate cancer: a ipooled analysisi
    Mascia, I. V.
    Monari, F.
    Massaccesi, M.
    Picardi, V.
    Frascino, V.
    Macchia, G.
    Cammelli, S.
    Deodato, F.
    Valentini, V.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S675 - S676
12345